About Index Trending news
Analyze
Pricing

Therapeutics

100+ Companies
Companies

Growing

177
Funding and Acquisitions

2017 Q2

22 + 0
Curators of Therapeutics
$15,100,000 Venture capital (Series B)
sdbj

Aspyrian Therapeutics Raises $15.1 Million | San Diego Business Journal

$35,000,000 Undisclosed funding
thepharmaletter , La Vanguardia

Grifols acquires minority stake in US biotech firm

$62,000,000 Venture capital (Series C)
PE Hub

Complexa lands $62 mln Series C

Data leaks
PE Hub

VC-backed Atlantic Therapeutics appoints Nye as chairman

Funding Health
$13,000,000 Post-IPO equity
BizWest

Pharmaceutical firm in Louisville raises $13 million

$1,250,000 Grant
prnewswire

Sphere Fluidics Limited and Partners Win Major InnovateUK Grant to Develop the World's First Desktop Genome Editing System

Xconomy

Acer Therapeutics Announces Reverse Merger With Houston’s Opexa

Health Strategy
$14,300,000 Venture capital (Series B)
texastechpulse , prnewswire

Lung Therapeutics Gets $14.3M

$2,370,000 Seed fund
Labiotech.eu , MedWatch

This Danish Biotech Thinks it Can Tackle the Obesity Epidemic

$8,000,000 Seed fund
businesswire

Synspira Announces $8 Million in Funding and Board of Directors

$75,000,000 IPO
PE Hub

VC-backed Mersana Therapeutics debuts IPO

Stock markets Health
$7,000,000 Post-IPO equity
businesswire

MetaStat Closes First Round of a $7 Million Private Placement

Xconomy

Neos Therapeutics’ Controlled-Release ADHD Drug Get FDA Approval

Health
$50,000,000 Venture capital (Series D)
PE Hub

Omada Health reels in $50 mln

Messaging
$2,100,000 Grant
Drug Delivery Business

Brainstorm lands $2.1m Israeli grant for NurOwn stem cell therapy

$15,000,000 Venture capital (Series G)
Twitter , PE Hub , FinSMEs , +1

NeuroBrain on Twitter

€1,700,000 Grant
businesswire

OMEICOS Secures Continued BMBF Support with New €1.7M Research Grant to Advance its Novel Approach to Treat Cardiovascular Diseases

$6,700,000 Post-IPO equity
BizWest

AntriaBio raises $6.7M, plans to file new drug application

Xconomy

RNA Specialist Arcturus Therapeutics Gets $3M R&D Grant for CF Drug

Science Health
$65,000,000 Venture capital (Series B)
PE Hub

Iterum grabs $65 mln Series B

Messaging